Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest announcement is out from Auna S.A. Class A ( (AUNA) ).
On March 10, 2026, Auna reported its fourth-quarter and full-year 2025 results, showing flat reported revenue for the year at S/4,385 million but a 35% jump in free cash flow and a sharp rise in adjusted net income to S/336 million. Adjusted EBITDA and margins declined year-on-year, yet Peru and Colombia performed solidly, oncology medical loss ratios hit record lows, and a major US$825 million refinancing left net leverage steady at 3.6x.
The company highlighted ongoing operational recovery in Mexico, including leadership changes, improved insurer tiering and contract wins that are already lifting volumes in early 2026. Auna also secured approval to refurbish and open the Centro Ambulatorio Trecca in Lima by 2028, expanded risk-sharing models in Colombia, and issued 2026 guidance targeting around 12% revenue and adjusted EBITDA growth, underscoring plans to restore growth, strengthen its regional platform and gradually reduce leverage below 3x.
The most recent analyst rating on (AUNA) stock is a Hold with a $7.00 price target. To see the full list of analyst forecasts on Auna S.A. Class A stock, see the AUNA Stock Forecast page.
Spark’s Take on AUNA Stock
According to Spark, TipRanks’ AI Analyst, AUNA is a Neutral.
Auna S.A. Class A’s overall stock score is primarily influenced by its stable financial performance and undervaluation, despite technical indicators suggesting a bearish trend. The earnings call highlighted regional strengths but also significant challenges, particularly in Mexico. The lack of corporate events further emphasizes the need for strategic improvements to enhance investor confidence.
To see Spark’s full report on AUNA stock, click here.
More about Auna S.A. Class A
Auna S.A. is a leading integrated healthcare platform in Latin America, operating in Mexico, Peru and Colombia. The company provides oncology and broader healthcare delivery services, leveraging its AunaWay model that combines payor relationships, physician alignment and care networks, with a focus on privately insured families and risk-sharing arrangements with payors.
Average Trading Volume: 364,018
Technical Sentiment Signal: Sell
Current Market Cap: $353M
Find detailed analytics on AUNA stock on TipRanks’ Stock Analysis page.